Clinical Practice Guideline 2015: Oral Hypoglycemic Agents for Patients with Type 2 Diabetes.

Author: Seung Hyun KO ¹
Author Information

1. Division of Endocrinology and Metabolism, Department of Internal Medicine, College of of Medicine, The Catholic University of Korea, Seoul, Korea. kosh@catholic.ac.kr
Publication Type:Practice Guideline ; Original Article
Keywords: Diabetes mellitus type 2; Hypoglycemic agents; Treatment guideline
MeSH: Humans; Hypoglycemic Agents*; Insulin
From:Journal of Korean Diabetes 2016;17(2):83-87
CountryRepublic of Korea
Language:Korean
Abstract: The revised Clinical Practice Guideline (5th edition) for patients with diabetes was released in November 2015 by the Korean Diabetes Association. Strict glycemic control is emphasized for the prevention and progression of diabetes-related vascular complications. The recommended target goal of HbA1c is less than 6.5%, especially for patients with recently diagnosed type 2 diabetes. To achieve this target goal, various classes of oral hypoglycemic agents and insulin should be initiated promptly, according to the patient's clinical situation. Accurate and up-to-date information about the available oral hypoglycemic agents will help increase glycemic control and diabetes management.